PRAETORIAN
2020
Subcutaneous vs Transvenous Defibrillator Therapy
In 849 patients needing a defibrillator but no pacing, a subcutaneous ICD was non-inferior to a transvenous ICD for device complications and inappropriate shocks.
Result
Efficacy: Device complications + inappropriate shocksHR 0.99 (95% CI 0.71-1.39) · P = 0.01
Below 1 favours subcutaneous ICD, above 1 favours a transvenous ICD.
- Absolute difference
- 0.6 points
The absolute difference is derived from the event rates.
Also reported: Non-inferior; P=0.95 superiority.
- Subtopic
- ICD
- Design
- RCT, non-inferiority
- Relevance
- Important: one of several pillars.
- Cited in
- ESC 2022 VA/SCD
- Source
- Knops RE, et al. N Engl J Med. 2020;383(6):526-536.doi 10.1056/NEJMoa1915932
Discussion & critique
Trades lead complications for more inappropriate shocks and no pacing or anti-tachycardia therapy. Suits patients with no pacing or resynchronisation indication.